Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Rheumatology|September 2, 2021
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology AllianceBonnie L Bermas, Milena Gianfrancesco, Helen L Tanner, et al.
RMD Open|September 13, 2022
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registrySu-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, et al.
RMD Open|September 14, 2022
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyMichael DiIorio, Kevin Kennedy, Jean W Liew, et al.
RMD Open|September 8, 2021
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveySebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, et al.
Arthritis Care & Research|August 29, 2023
Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance RegistryJinoos Yazdany, Anna Ware, Zachary S Wallace, et al.
ACR Open Rheumatology|July 23, 2022
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance RegistryZara Izadi, Milena A Gianfrancesco, Alfredo Aguirre, et al.
The Lancet. Rheumatology|August 1, 2022
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational studyZara Izadi, Milena A Gianfrancesco, Gabriela Schmajuk, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
JAMA Network Open|October 18, 2021
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19Zara Izadi, Erica J Brenner, Satveer K Mahil, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, et al.
Pageof 9